EP3845215
LAUSNIR TIL INNTÖKU SEM FELA Í SÉR LISDEXAMFETAMÍN SÖLT
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.12.2019EP published:
27.7.2022EP application number:
19386059.0
EP translation filed:
4.10.2022Grant published:
15.11.2022EPO information:
European Patent Register
Max expiry date:
29.12.2039Expiry date:
29.12.2026Next due date:
31.12.2026
Title in English:
ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTSLanguage of the patent:
English
Timeline
Today
30.12.2019EP application
27.7.2022EP Publication
4.10.2022Translation submitted
15.11.2022Registration published
29.12.2026Expires
Owner
Name:
LABOMED PHARMACEUTICAL COMPANY S.A.Address:
Ioannou Metaxa 84, 19441 Koropi, Attica, GR
Inventor
Name:
Liolios, GeorgiosAddress:
15232 Chalandri Attica, GR
Name:
Psarrakis, IoannisAddress:
19500 Lavrion, GR
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Classification
Categories:
A61K 9/00, A61K 9/08, A61K 31/4015, A61K 47/10, A61P 25/26
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 22.12.2022
Expires: 29.12.2023
Payer: Árnason Faktor ehf.
Number: 5
Paid: 22.12.2023
Expires: 29.12.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 13.12.2024
Expires: 29.12.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 29.12.2025
Expires: 29.12.2026
Payer: Árnason Faktor ehf.